Implementation of Genotype-Guided Antiplatelet Therapy Feasible but Not Without Obstacles

被引：3

作者：

Lewis, Joshua P. ^{[1
]}

机构：

[1] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Program Personalized & Genom Med, Baltimore, MD 21201 USA

来源：

CIRCULATION-GENOMIC AND PRECISION MEDICINE | 2018年 / 11卷 / 04期

基金：

美国国家卫生研究院;

关键词：

Editorials; aspirin; clopidogrel; genotype; percutaneous coronary intervention; pharmacogenetics; PERCUTANEOUS CORONARY INTERVENTION; CYP2C19; GENOTYPE; CLOPIDOGREL THERAPY; ASSOCIATION; GUIDELINES; OUTCOMES;

D O I：

10.1161/CIRCGEN.118.002118

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 12 条

[1] Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention [J].

Cavallari, Larisa H. ;

Lee, Craig R. ;

Beitelshees, Amber L. ;

Cooper-DeHoff, Rhonda M. ;

Duarte, Julio D. ;

Voora, Deepak ;

Kimmel, Stephen E. ;

McDonough, Caitrin W. ;

Gong, Yan ;

Dave, Chintan V. ;

Pratt, Victoria M. ;

Alestock, Tameka D. ;

Anderson, R. David ;

Alsip, Jorge ;

Ardati, Amer K. ;

Brott, Brigitta C. ;

Brown, Lawrence ;

Chumnumwat, Supatat ;

Clare-Salzler, Michael J. ;

Coons, James C. ;

Denny, Joshua C. ;

Dillon, Chrisly ;

Elsey, Amanda R. ;

Hamadeh, Issam S. ;

Harada, Shuko ;

Hillegass, William B. ;

Hines, Lindsay ;

Horenstein, Richard B. ;

Howell, Lucius A. ;

Jeng, Linda J. B. ;

Kelemen, Mark D. ;

Lee, Yee Ming ;

Magvanjav, Oyunbileg ;

Montasser, May ;

Nelson, David R. ;

Nutescu, Edith A. ;

Nwaba, Devon C. ;

Pakyz, Ruth E. ;

Palmer, Kathleen ;

Peterson, Josh F. ;

Pollin, Toni I. ;

Quinn, Alison H. ;

Robinson, Shawn W. ;

Schub, Jamie ;

Skaar, Todd C. ;

Smith, D. Max ;

Sriramoju, Vindhya B. ;

Starostik, Petr ;

Stys, Tomasz P. ;

Stevenson, James M. .

JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (02) :181-191

[2] CYP2C19 Poor Metabolizer Is Associated With Clinical Outcome of Clopidogrel Therapy in Acute Myocardial Infarction But Not Stable Angina [J].

Kim, Ho-Sook ;

Chang, Kiyuk ;

Koh, Yoon-Seok ;

Park, Mahn-Won ;

Choi, Yun-Seok ;

Park, Chul-Soo ;

Oh, Minkyung ;

Kim, Eun-Young ;

Shon, Ji-Hong ;

Shin, Jae-Gook ;

Seung, Ki-Bae .

CIRCULATION-CARDIOVASCULAR GENETICS, 2013, 6 (05) :514-521

[3] Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention [J].

Lee, Craig R. ;

Sriramoju, Vindhya B. ;

Cervantes, Alexandra ;

Howell, Lucius A. ;

Varunok, Nicholas ;

Madan, Shivanshu ;

Hamrick, Kasey ;

Polasek, Melissa J. ;

Lee, John Andrew ;

Clarke, Megan ;

Cicci, Jonathan D. ;

Weck, Karen E. ;

Stouffer, George A. .

CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (04) :e002069

[4]

Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007

[5] Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent [J].

Sanchez-Ramos, Jesus ;

Lucia Davila-Fajardo, Cristina ;

Toledo Frias, Pablo ;

Diaz Villamarin, Xando ;

Javier Martinez-Gonzalez, Luis ;

Martinez Huertas, Susana ;

Burillo Gomez, Francisco ;

Caballero Borrego, Juan ;

Bautista Paves, Alicia ;

Marin Guzman, Ma Carmen ;

Ramirez Hernandez, Jose Antonio ;

Correa Vilches, Concepcion ;

Cabeza Barrera, Jose .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 225 :289-295

[6] Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update [J].

Scott, S. A. ;

Sangkuhl, K. ;

Stein, C. M. ;

Hulot, J-S ;

Mega, J. L. ;

Roden, D. M. ;

Klein, T. E. ;

Sabatine, M. S. ;

Johnson, J. A. ;

Shuldiner, A. R. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (03) :317-323

[7] Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population [J].

Shen, De-Liang ;

Wang, Bo ;

Bai, Jing ;

Han, Qing ;

Liu, Chuang ;

Huang, Xiao-Hui ;

Zhang, Jin-Ying .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 67 (03) :232-236

[8] Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy [J].

Shuldiner, Alan R. ;

O'Connell, Jeffrey R. ;

Bliden, Kevin P. ;

Gandhi, Amish ;

Ryan, Kathleen ;

Horenstein, Richard B. ;

Damcott, Coleen M. ;

Pakyz, Ruth ;

Tantry, Udaya S. ;

Gibson, Quince ;

Pollin, Toni I. ;

Post, Wendy ;

Parsa, Afshin ;

Mitchell, Braxton D. ;

Faraday, Nauder ;

Herzog, William ;

Gurbel, Paul A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (08) :849-858

[9] CYP2C19 Genotype Has a Greater Effect on Adverse Cardiovascular Outcomes Following Percutaneous Coronary Intervention and in Asian Populations Treated With Clopidogrel A Meta-Analysis [J].

Sorich, Michael J. ;

Rowland, Andrew ;

McKinnon, Ross A. ;

Wiese, Michael D. .

CIRCULATION-CARDIOVASCULAR GENETICS, 2014, 7 (06) :895-U387

[10] Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes [J].

Wallentin, Lars ;

Becker, Richard C. ;

Budaj, Andrzej ;

Cannon, Christopher P. ;

Emanuelsson, Hakan ;

Held, Claes ;

Horrow, Jay ;

Husted, Steen ;

James, Stefan ;

Katus, Hugo ;

Mahaffey, Kenneth W. ;

Scirica, Benjamin M. ;

Skene, Allan ;

Steg, Philippe Gabriel ;

Storey, Robert F. ;

Harrington, Robert A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11) :1045-1057

← 1 2 →